Core Insights - The event "Hand in Hand with Hong Kong, Discussing the Future" was successfully held in Hong Kong, organized by Shuangyi Pharmaceutical and RaffAello, focusing on corporate development, industry trends, and investment opportunities [1][3] - Chairman Wang Bo emphasized that 2026 is a critical year for Shuangyi Pharmaceutical's transformation and high-quality development, aiming to leverage Hong Kong's international financial advantages to showcase Guangxi's achievements and promote key products globally [3][5] Company Strategy - Shuangyi Pharmaceutical is committed to implementing a "dual brand" strategy, aiming to establish its flagship product, Shuangyi Qushi Tongluo Capsule, as a global leader while also striving to make its compound cold medicine granules a market champion [5] - The company plans to expand its business both domestically and internationally, focusing on product-centric and market-oriented approaches, with a vision to enhance collaboration with partners for broader development opportunities [5] Industry Reception - Attending fund managers praised Shuangyi Pharmaceutical's dedication to ethnic Zhuang medicine and its commitment to independent innovation, recognizing the company's growth journey as a testament to resilience and potential [5] - The overall atmosphere of the event was positive, with deep exchanges and interactions, reflecting the company's commitment to its corporate spirit of unity, diligence, perseverance, and innovation [6]

Core Viewpoint - Guizhou Province's "14th Five-Year Plan" has led to significant economic and social development, with a focus on building a modern industrial system and leveraging local advantages for sustainable growth [1][3][9]. Economic Development - Guizhou's GDP has surpassed 150 billion yuan, with notable achievements in industrial growth, including the establishment of two 10 billion yuan industries and parks [3]. - The region has seen rapid growth in specialty agriculture, leading the province in the cultivation of various crops such as medicinal herbs and blueberries [3][4]. Cultural and Tourism Integration - The integration of culture and tourism has resulted in over 2.8 billion online views of local events, showcasing the vibrant image of Qiandongnan [4]. - The region has established the first national cultural ecological protection zone in the province, with tourist numbers exceeding 100 million and total tourism expenditure surpassing 100 billion yuan [4]. Environmental and Social Achievements - Qiandongnan has been recognized as a national model for ethnic unity and has maintained top rankings in ecological indicators such as water quality and forest coverage [6]. - The community demonstrated resilience and solidarity during natural disasters, highlighting the strength of local support systems [7]. Industrial Strategy - The region aims to develop a "4+2" industrial system focusing on deep processing of mineral resources, recycling materials, ethnic food, and medicine, while also promoting wood processing and light industry [9][11]. - In agriculture, a "5+3" system will be implemented to enhance the cultivation of medicinal herbs, oil tea, and blueberries, alongside livestock and aquaculture [9][11]. Tourism Development - The tourism strategy includes a "1+4" framework to enhance the region's appeal as a destination, leveraging its rich cultural and natural resources [11]. - The focus will be on integrating tourism with local culture, health, and agriculture to create a comprehensive tourism experience [11]. Implementation and Future Plans - The current year marks the beginning of the "15th Five-Year Plan," with an emphasis on implementing supportive policies for high-quality development and attracting major projects [12]. - The goal is to increase the number of counties with GDP exceeding 10 billion yuan to nine by the end of the "15th Five-Year Plan" [12].

转自：中国市场监管报 该标准是我国民族医药领域首部疾病分类国家标准，其出台标志着藏医药标准化建设迈出关键一步，对 藏医医疗服务的规范化、科学化发展具有重要意义。具体作用表现在以下四个方面：一是统一疾病名称 体系，有效解决藏医药存在的"一病多名、同病异名"等问题，为临床诊断、学术交流和医疗管理提供统 一依据；二是突出藏医临床特色，系统梳理和体现藏医优势病种，有助于发挥藏医药在特定疾病防治中 的独特作用；三是支撑医疗质量管控，为藏医医疗服务质量控制、效果评价与管理监督提供科学的监测 指标，助力藏医服务水平持续提升；四是促进数据平台建设，为构建藏医药大数据平台奠定基础，同时 也可为医保结算、卫生统计等信息化工作提供可靠数据支撑。 本报讯 近日，市场监管总局（国家标准委）批准发布《藏医疾病分类与代码》（GB/T 46946—2025） 推荐性国家标准。该标准由国家中医药管理局组织起草，将自4月1日起正式实施。 □叶 昀 （来源：中国市场监管报） 《藏医疾病分类与代码》遵从藏医学术理论本体、满足藏医临床诊断需求，将藏医疾病分为三大基因病 等15大类和隆病等97节细类，并编制藏医疾病名术语与分类代码表，规定了3000多种 ...

Core Viewpoint - The approval and implementation of the "Tibetan Medicine Disease Classification and Codes" national standard marks a significant step in the standardization of Tibetan medicine in China, enhancing clinical diagnosis and healthcare management in this field [1] Group 1: Standard Overview - The standard categorizes Tibetan medicine diseases into three major categories and 97 subcategories, including over 3,000 disease codes and names in both Tibetan and Chinese [1] - It is the first national disease classification standard in the field of ethnic medicine in China, indicating a milestone in the development of Tibetan medicine [1] Group 2: Key Functions - The standard unifies the disease naming system, addressing issues of "multiple names for one disease" and "different names for the same disease," providing a consistent basis for clinical diagnosis, academic exchange, and healthcare management [1] - It highlights the clinical characteristics of Tibetan medicine, systematically organizing and showcasing its advantageous disease types, which aids in leveraging Tibetan medicine's unique role in the prevention and treatment of specific diseases [1] - The standard supports quality control in healthcare, providing scientific monitoring indicators for evaluating and supervising the quality of Tibetan medical services, thereby enhancing service levels [1] - It promotes the construction of a data platform, laying the groundwork for a big data platform for Tibetan medicine, and providing reliable data support for medical insurance settlement and health statistics [1]

Core Insights - The establishment of the Public Health Professional Committee of the China National Medicine Association marks a new beginning for the integration of traditional Chinese medicine and public health, aiming to enhance public health services and promote high-quality development in national traditional medicine [2][3][10] Group 1: Event Overview - The founding conference and the first academic meeting on national public health development took place at Weifang Nursing Vocational College, gathering leaders from government, healthcare institutions, and experts in traditional medicine and public health [1] - The event was hosted by the Vice President of Weifang Nursing Vocational College, highlighting the college's achievements and its role in leading the committee [5][10] Group 2: Government and Institutional Support - The Vice Mayor of Weifang, Chen Weisong, emphasized the city's achievements in traditional medicine and expressed hope that the college would lead the committee to explore new paths for integrating traditional medicine with public health [2] - The committee aims to become a national platform for the integration of traditional medicine and public health, supported by the Weifang government [2][10] Group 3: Committee Objectives and Vision - The honorary chairman of the committee, Wang Xinlu, stated the importance of prioritizing public health and integrating traditional medicine into all areas of public health [2][3] - The committee is tasked with developing a theoretical system for public health that incorporates traditional medicine, promoting standardized techniques, and enhancing international collaboration [3][4] Group 4: Academic Contributions and Discussions - The conference featured various presentations on topics such as the role of traditional medicine in epidemic prevention and the impact of environmental factors on health, showcasing the intersection of traditional and modern medical practices [9][10] - Experts discussed innovative solutions for public health challenges and the need for interdisciplinary collaboration in training and research [9][10]

Core Viewpoint - The research team from Beijing Normal University visited Guangxi Shuangyi Pharmaceutical Co., Ltd. to study the development of ethnic medicine and its industrialization in the context of regional development in ethnic areas [1] Group 1: Company Overview - Guangxi Shuangyi Pharmaceutical is recognized as a national high-tech enterprise and a "specialized, refined, distinctive, and innovative" small and medium-sized enterprise in Guangxi [7] - The company has developed a unique product, the Shuangyi Dampness-Removing Capsule, which is the first recognized Zhuang medicine, utilizing traditional Zhuang medical formulas and modern production techniques [3][8] Group 2: Product Development and Quality - The company emphasizes quality control, with internal standards exceeding national requirements, reflecting its commitment to public health [3] - The annual sales of the compound cold medicine granules exceed 100 million, showcasing the company's successful product line in the Zhuang medicine sector [3] Group 3: Research and Development - The company has established the "Guangxi Zhuang Autonomous Region Medicinal Animal Engineering Research Center," focusing on the research and development of Zhuang and Yao medicines, and holds multiple invention patents [8] - The integration of traditional medicine with modern technology is a key strategy for the company, aiming to modernize ethnic medicine [8] Group 4: Community Engagement and Sustainability - The company employs a "company + cooperative + farmer" model to promote the cultivation of Zhuang and Yao medicinal materials, supporting local communities and ensuring a stable supply of raw materials for production [5] - The establishment of a dedicated medicinal material planting base in the "World Yao Capital" Jinxi Yao Autonomous County enhances the scale and standardization of Zhuang and Yao medicinal resources [5] Group 5: Future Goals - The company aims to continue promoting Zhuang and Yao medical culture, deepen industry-academia-research cooperation, and establish itself as a leader in the production of anti-cold and rheumatism medications in China [10] - The long-term goal is to contribute significantly to the modernization of ethnic regions through the development of the ethnic medicine industry [10]

Core Viewpoint - The 20th Central Committee's Fourth Plenary Session emphasizes improving the quality of people's lives as a primary goal for the 14th Five-Year Plan period, guiding Qinghai's development towards a modernized society that resonates with public welfare [1] Group 1: Strengthening the Foundation of People's Livelihood - Qinghai aims to enhance infrastructure and long-term guarantees to solidify the foundation for a happy life, transitioning from merely addressing shortcomings to improving quality and efficiency in public services [1][2] - Past initiatives, such as road expansions and health facility upgrades, have transformed struggling areas into model communities, highlighting the importance of infrastructure in enhancing public welfare [1][2] Group 2: Enhancing Governance Effectiveness - The focus is on improving soft power and service quality to enrich the new connotations of happiness, shifting public expectations from mere availability to quality of services [2][3] - Initiatives like the "Pomegranate Seed Home" brand in communities aim to strengthen ethnic unity and integrate traditional medicine into healthcare, promoting social harmony and health security [2][3] Group 3: Innovative Grassroots Governance - A system combining party leadership, multi-party cooperation, and digital empowerment is being developed to enhance community governance and responsiveness to public needs [3] - The establishment of a comprehensive governance platform aims to foster a community culture that embraces diversity and cooperation [3] Group 4: Activating Circular Economic Dynamics - The integration of economic development and public welfare is seen as essential, with examples of local communities achieving economic success through specialized industries [3][4] - Future strategies will focus on ensuring that development outcomes benefit public welfare and that improvements in public welfare stimulate further economic growth [3][4] Group 5: Industry Empowerment for Public Welfare - The creation of an "ecological + characteristic + brand" industry system is prioritized, with a focus on developing eco-tourism and regional public brands to enhance sales channels [4] - The aim is to transform health, stability, and talent benefits from mere guarantees into value outputs, thereby converting public welfare advantages into core competitive strengths for regional development [4]

Core Viewpoint - The release of two local standards for traditional medicine in Guangxi aims to enhance the development and innovation of ethnic medicine, providing more specialized healthcare support for the public [1] Group 1: Standards Released - The "Nian Nao Nuo (Sleep Disorders) Zhuang Medicine Diagnosis and Treatment Specification" and the "Jing Ethnic Medicine Clinical Diagnosis and Treatment Technical Operation Specification for Gallstone Disease" have been officially published [1] - These standards will be implemented starting March 30, 2026, marking a significant step in the standardization of ethnic medical practices in Guangxi [1] Group 2: Zhuang Medicine - The Zhuang people refer to insomnia as "Nian Nao Nuo," and the newly published specification organizes classic prescriptions and techniques for treating sleep disorders, providing a scientific and unified operational guide for clinical practice [1] - The specification clarifies the diagnostic classification and treatment pathways that combine internal and external therapies [1] Group 3: Jing Ethnic Medicine - Jing ethnic medicine is recognized as the only marine ethnic medical system in China with a dedicated medical monograph [1] - The new standard for gallstone disease treatment aims to standardize and normalize effective folk treatment experiences from the Jing ethnic community [1] Group 4: Impact on Healthcare - The standardization of diagnosis and treatment practices is seen as a technical support for the high-quality development of ethnic medicine [1] - By regulating treatment behaviors and unifying technical standards, the initiative is expected to enhance the service capabilities of grassroots medical institutions and promote the transformation of academic achievements in ethnic medicine [1] - This effort aims to strengthen the influence of the "Gui" brand in traditional Chinese medicine [1]

Group 1 - The Guizhou provincial government organized a delegation of health and pharmaceutical companies to participate in the 30th Macao International Trade and Investment Fair (MIF) to enhance economic cooperation with Portuguese-speaking countries and connect with the Guangdong-Hong Kong-Macao Greater Bay Area market [2] - The participating companies include Guizhou Yibai Health Pharmaceutical, Guizhou Bailing Group, and several others focusing on ethnic medicine innovation and modern biotechnology [2] - The event showcased Guizhou's unique health products, emphasizing the integration of traditional wisdom and modern technology in the pharmaceutical sector [4] Group 2 - Key products highlighted include classic medicines represented by Miao medicine, authentic medicinal materials like Tianma and Dendrobium, and functional foods derived from Huangjing and prickly pear, reflecting Guizhou's rich natural resources [4] - Guizhou Jinchaolan Biotechnology Co., Ltd. secured orders worth 20 million RMB with local companies in Macao, while Guizhou Yibai Health Pharmaceutical reached a cooperation agreement for the registration of functional foods in Brazil [4] - The Guizhou provincial government aims to leverage the MIF as an international platform to seek more global cooperation opportunities and expand overseas marketing channels [4]

Core Viewpoint - Guangxi is gradually building a health brand matrix and exploring a unique "Two Mountains" transformation model 2.0, aiming to establish ten major ecological health brands by 2027, enhancing its reputation as a livable and travel-friendly destination [1] Group 1: Strategic Development - Guangxi is positioning the health industry as a strategic pillar, supported by policies like the "Ecological Civilization Construction Promotion Regulations" and the "Three-Year Action Plan for Ecological Environment and Health Brand Construction (2025-2027)" [1] - The region aims to upgrade its health brands from "existing" to "superior" through a clear brand construction system with defined goals and responsibilities [1] Group 2: Traditional Brand Strengthening - By 2024, Guangxi will have 1,866 green, organic, and geographical indication agricultural products, with the "Gui" brand agricultural output value exceeding 160 billion yuan and total value surpassing 500 billion yuan [2] - The establishment of 38 national and 53 regional forest health bases is expected to generate over 230 billion yuan in combined income from forest health and eco-tourism by 2024 [2] - The region is leveraging its ethnic medicine advantages, with 82 traditional Chinese medicine demonstration bases and 40 health tourism demonstration bases [2] Group 3: Brand Value Enhancement - Guangxi has hosted ecological health brand construction activities for two consecutive years and organized six promotional events in various provinces since 2024 [3] - The region is actively promoting its ecological advantages, with notable sites like the Lijiang River and Naka River recognized as beautiful rivers, and the air quality maintaining a 93.9% good rate from January to September 2025 [3] - The completion rate for rectifying heavy pollution issues stands at 86.6%, with a high proportion of good water quality in national monitoring sections [3]